More about

Tb

News
February 14, 2025
3 min read
Save

Trial identifies new all-oral drug regimens for rifampin-resistant TB

Trial identifies new all-oral drug regimens for rifampin-resistant TB

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of rifampin-resistant tuberculosis, according to a study.

News
November 08, 2024
1 min read
Save

Hooked on ID with Vani Vannappagari, MBBS, PhD, MPH

Hooked on ID with Vani Vannappagari, MBBS, PhD, MPH

As a physician trained in India, I saw the devastating impact of infectious diseases like TB, malaria and waterborne illnesses, and the profound difference public health interventions can have. That led to my career in global health.

News
November 08, 2024
4 min read
Save

Safer, shorter regimens needed for latent TB infection

Safer, shorter regimens needed for latent TB infection

It is estimated that approximately one-quarter of the world’s population has latent tuberculosis infection (LTBI). Although effective therapies are available, these agents can have significant adverse effects that can complicate treatment.

News
November 28, 2023
1 min read
Save

Top in ID: Free COVID-19 tests; shorter antibiotic duration for gram-negative bacteremia

Top in ID: Free COVID-19 tests; shorter antibiotic duration for gram-negative bacteremia

The Biden administration is offering more free COVID-19 tests ahead of the holiday season.

News
September 18, 2023
2 min read
Save

Pregnant women receiving effective resistant TB treatment had ‘excellent outcomes’

Pregnant women receiving effective resistant TB treatment had ‘excellent outcomes’

Pregnant women who received effective multidrug-resistant/rifampicin-resistant tuberculosis treatment regimens had positive outcomes with no major negative impacts on their infants, researchers reported.

News
July 17, 2023
1 min read
Save

Infliximab effective as adjunctive therapy for patients with central nervous system TB

Infliximab effective as adjunctive therapy for patients with central nervous system TB

Infliximab was found to be safe and effective as adjunctive therapy for patients with central nervous system tuberculosis, researchers reported.

News
March 24, 2023
5 min read
Save

World TB Day: Is TB vaccine and treatment research back on track?

World TB Day: Is TB vaccine and treatment research back on track?

Throughout the COVID-19 pandemic, World TB Day, which is observed each year on March 23, has marked the need for more — more research, more testing, more treatment options, and more access for patients globally.

News
March 23, 2023
2 min read
Save

TB on rebound in US, but cases remain below pre-pandemic levels, CDC says

TB on rebound in US, but cases remain below pre-pandemic levels, CDC says

Cases of tuberculosis increased in the U.S. in 2022 but did not return to pre-pandemic levels, according to data published in a Morbidity and Mortality Weekly Report ahead of World TB Day.

News
January 13, 2023
2 min read
Save

More than half of patients with TB had no symptoms before testing positive

More than half of patients with TB had no symptoms before testing positive

Researchers found high rates of tuberculosis among high-risk patients who sought care at primary health care clinics, many of whom had no preceding symptoms suggesting a high rate of subclinical TB.

News
December 08, 2022
2 min read
Save

Majority of patients with TB eligible for shortened therapy continued a prolonged course

Majority of patients with TB eligible for shortened therapy continued a prolonged course

Many patients with tuberculosis who were potentially eligible for a shorter 4-month therapy were treated with standard 6-month courses, according to a recent study.

View more